Literature DB >> 17432012

Helicobacter pylori infection in asymptomatic subjects in Makkah, Saudi Arabia.

Mubashir A Khan1, Hani O Ghazi.   

Abstract

OBJECTIVE: To determine the seroprevalence of Helicobacter.pylori antibodies in asymptomatic healthy population.
METHODS: Convenient sampling was done in asymptomatic healthy individuals accompanying the patients who had no previous history of epigastric pain. Venous blood was collected from individuals and sera separated. Enzyme-linked immunosorbent assay (ELISA) was used to determine H. pylori IgG antibodies in all sera.
RESULTS: A total of 396 samples were collected. H. pylori antibodies were found in 201 (51%) individuals. A 46% seroprevalence was found in subjects 15-20 years of age, which gradually increased with age and reached to .61% in subjects up to 50 years of age. Subjects > 40 years had higher antibody response than those < 40 years. There was no significant association between presence of H. pylori antibodies and dietary habits and sources of drinking water. H. pylori antibodies in female smokers were found in 9% and in non smoking females were 91% but no such difference was found in male smokers or non-smokers.
CONCLUSION: Infection with H. pylori is prevalent in the healthy individuals of Makkah, Saudi Arabia. Infection is acquired in the early age and reaches up to 61% as the age advances. A nation wide epidemiological study is warranted to determine the seroprevalence of H. pylori in Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432012

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  20 in total

Review 1.  Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors.

Authors:  Ahad Eshraghian
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010).

Authors:  Fatemeh Ghasemi Kebria; Haniye Bagheri; Shahryar Semnani; Ezatollah Ghaemi
Journal:  Caspian J Intern Med       Date:  2011

3.  Prevalence of Helicobacter pylori infection in a group of morbidly obese Saudi patients undergoing bariatric surgery: a preliminary report.

Authors:  Ahmad M Al-Akwaa
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

Review 4.  Helicobacter pylori Infection in the general population: A Middle Eastern perspective.

Authors:  Hossein Khedmat; Reza Karbasi-Afshar; Shahram Agah; Saeed Taheri
Journal:  Caspian J Intern Med       Date:  2013

5.  Barrett esophagus: perspectives on its diagnosis and management in asian populations.

Authors:  Yuji Amano; Yoshikazu Kinoshita
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

Review 6.  Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact?

Authors:  Waleed I Albaker
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

7.  Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients.

Authors:  Mohamad Salih Jaff
Journal:  Clin Exp Gastroenterol       Date:  2011-09-19

8.  Seroprevalence of anti-Helicobacter pylori and anti-cytotoxin-associated gene A antibodies among healthy individuals in center of Iran.

Authors:  Saeideh Afsharipour; Razieh Nazari; Masoumeh Douraghi
Journal:  Iran J Basic Med Sci       Date:  2014-08       Impact factor: 2.699

9.  Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.

Authors:  Fahad Alsohaibani; Hamad Al Ashgar; Khalid Al Kahtani; Ingvar Kagevi; Musthafa Peedikayil; Abdulrahman Alfadda; Mohammed Khan
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

Review 10.  Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.

Authors:  Mohammed Rizwan; Nuzhath Fatima; Ayesha Alvi
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.